Presentation TCT 2012

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Roxana Mehran

October 25, 2012

REGISTER for free or LOG IN to view this content

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

CAD Pharma

ACS/AMI

Presentation

TCT 2012

Up Next

Presentation TCT 2012

"Impact of the Presence and Extent of Incomplete Angiographic Revascularization after Percutaneous Coronary Intervention in Acute Coronary Syndromes: The ACUITY Trial."...

Presenter: Gregg Rosner

October 24, 2012

More slides +

Presentation TCT 2012

Drip, Ship, and Fix or Drip, Ship, and Wait?

Presenter: Christopher Buller

October 24, 2012

Presentation TCT 2012

Phase II and III Clinical Trials: Off and Running!

Presenter: Amit Patel

October 22, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.